Business
AbCellera to Participate at Upcoming Investor Conferences in March
VANCOUVER, British Columbia--(BUSINESS WIRE)-- AbCellera (Nasdaq: ABCL) today announced that the Company will participate in the following investor
About this update from Abcellera Biologics Inc.
[{"type":"text","content":" VANCOUVER, British Columbia--(BUSINESS WIRE)--\nAbCellera (Nasdaq: ABCL) today announced that the Company will participate in the following investor conferences:\n\n\n\n45th Annual TD Cowen Health Care Conference, March 3-5\n\n\n\nKeyBanc Capital Markets Healthcare Forum, March 18-19\n\n\n\nVisit AbCellera's Investor Relations website for additional information.\n\n\nAbout AbCellera Biologics Inc.\n\n\nAbCellera (Nasdaq: ABCL) discovers and develops antibody medicines for indications across therapeutic areas including cancer, metabolic and endocrine conditions, and autoimmune disorders. AbCellera’s engine integrates technology, data science, infrastructure, and interdisciplinary teams to solve the most challenging antibody discovery problems. AbCellera is focused on advancing an internal pipeline of first-in-class and best-in-class programs and collaborating on innovative drug development programs with partners. For more information, please visit www.abcellera.com.\n\nView source version on businesswire.com: https://www.businesswire.com/news/home/20250211013862/en/\n\nInquiries\nMedia: Tiffany Chiu; [email protected], +1(604)724-1242\nBusiness Development: Murray McCutcheon, Ph.D.; [email protected], +1(604)559-9005\nInvestor Relations: Peter Ahn; [email protected], +1(778)729-9116\n\n\nSource: AbCellera Biologics Inc.","length":3453,"tagName":"div"}]